$32.27
0.621.96%
近くで: Sep 23, 5:00 PM EST
$32.27
0.621.96%
プレマーケット: 6:38 AM EST
Benzinga
Benzinga
Benzinga
金曜日, 9 25
Caris Life Sciences Inc
CAINASDAQ
Caris Life Sciences Earnings & Forecasts
Caris Life Sciences (CAI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Caris Life Sciences Guidance
Caris Life Sciences (CAI) は、8 5, 2026日にfiscal yearの2026に関するガイダンスを直近で発表しました。同社は当期の売上高を$1.03B - $1.04Bの範囲と予想しています。
以前のガイダンスと比較して、Caris Life Sciencesは売上高予測を以前の範囲である引き上げから$1B - $1.02Bに引き上げました。
Caris Life Sciencesは、7から8 12, 2025の間に8 5, 2026ガイダンスの更新を発表しました。During this period, the company raised its outlook 4 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.01 | $-0.02 | $0.07 | $-0.11 |
| Actual | $0.00 | $0.00 | $0.28 | $0.08 |
| Surprise | -100.0% | +100.0% | +300.0% | +172.7% |
| Revenue | ||||
| Estimate | $237.0M | $209.5M | $280.9M | $173.7M |
| Actual | $263.7M | $216.2M | $292.9M | $216.8M |
| Surprise | +11.3% | +3.19% | +4.27% | +24.8% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.03 | $0.11 | $0.03 | $0.10 |
| Revenue | ||||
| Consensus | $254.7M | $292.9M | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved